HIV edible vaccine - ProdiGeneAlternative Names: HIV vaccine edible - ProdiGene
Latest Information Update: 12 Jan 2004
At a glance
- Originator ProdiGene
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 12 Jan 2004 No development reported - Preclinical for HIV-1 infections in USA (PO)
- 14 Nov 2003 This vaccine is still in active development
- 01 Dec 2000 Preclinical development for HIV-1 infections in USA (PO)